These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36077471)

  • 1. 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics.
    Plebani R; Bai H; Si L; Li J; Zhang C; Romano M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges.
    Wang Y; Wang P; Qin J
    Adv Sci (Weinh); 2022 Apr; 9(10):e2105187. PubMed ID: 35107217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineered
    Chakraborty J; Banerjee I; Vaishya R; Ghosh S
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6540-6555. PubMed ID: 33320635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection.
    Ni K; Che B; Yang C; Qin Y; Gu R; Wang C; Luo M; Deng L
    Front Pharmacol; 2022; 13():1033043. PubMed ID: 36578545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
    JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases.
    Wang Y; Wang P; Qin J
    Acc Chem Res; 2021 Sep; 54(18):3550-3562. PubMed ID: 34459199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primed for global coronavirus pandemic: Emerging research and clinical outcome.
    Ahamad S; Branch S; Harrelson S; Hussain MK; Saquib M; Khan S
    Eur J Med Chem; 2021 Jan; 209():112862. PubMed ID: 33070079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip.
    Dichtl S; Posch W; Wilflingseder D
    Eur J Immunol; 2024 Mar; 54(3):e2250356. PubMed ID: 38361030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.
    Giani AM; Chen S
    Stem Cell Res; 2021 May; 53():102207. PubMed ID: 33677394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting.
    de Melo BAG; Benincasa JC; Cruz EM; Maricato JT; Porcionatto MA
    Biomed J; 2021 Mar; 44(1):31-42. PubMed ID: 33602633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.
    Forchette L; Sebastian W; Liu T
    Curr Med Sci; 2021 Dec; 41(6):1037-1051. PubMed ID: 34241776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19.
    Bhavaniramya S; Ramar V; Vishnupriya S; Palaniappan R; Sibiya A; Vaseeharan B
    Curr Mol Pharmacol; 2022; 15(2):393-417. PubMed ID: 34382513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
    Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
    Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.